Enhancement of tumor lethality of ROS in photodynamic therapy

115Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the process of photodynamic therapy (PDT) treatment of tumors, reactive oxygen species (ROS) plays a key role in destroying tumor tissues. However, traditional PDT often has limited ROS killing capacity due to hypoxia in the tumor microenvironment (TME) or obstruction by the ROS defense system, resulting in poor efficacy. Therefore, enhancing the killing effect of ROS on tumors is the core of enhancing the anti-tumor effect of PDT. In recent years, many studies have developed a series of strategies to enhance the ability of ROS to kill tumors in view of the limitations of the TME on PDT. This article summarizes the commonly used or innovative strategies in recent years, including not only frequently used methods for hypoxia in the TME but also innovative strategies to inhibit the ROS defense system.

Cite

CITATION STYLE

APA

Ming, L., Cheng, K., Chen, Y., Yang, R., & Chen, D. (2021, January 1). Enhancement of tumor lethality of ROS in photodynamic therapy. Cancer Medicine. Blackwell Publishing Ltd. https://doi.org/10.1002/cam4.3592

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free